Skip to main content

Paired Ends: Catherine Burzik, Bill Ward

Premium

Becton, Dickinson has appointed Catherine Burzik to its board of directors. She was formerly the president of Applied Biosystems, before it was acquired by Life Technologies, and most recently was president, CEO, and director of Kinetic Concepts. Currently, she is chair of the board of directors of VitaPath Genetics, chair of the Canisius College board of trustees, a member of the board of directors of Canisius, and on the board of trustees of the Keck Graduate School of Applied Life Sciences. She holds a BS in mathematics from Canisius College and an MS in mathematics from the University of Buffalo.


ZS Genetics, a North Reading, Mass.-based next-generation sequencing startup, has appointed Bill Ward to president and chief operating officer. Ward was founder, president, and CEO of ALIS before Carl Zeiss acquired it. He was also founder of Micrion and Beam Technologies.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.